As of Jan 17, 2025, Stryker Corporation Intrinsic Value is $286.0. This suggests it may be overvalued by 25.4% compared to its current price of around $383.4.
As of Jan 17, 2025, Stryker Corporation's Discounted Cash Flow (DCF) valuation estimates its share price at $279.7. This suggests it may be overvalued by 27.0% to its current price of around $383.4, using a discount rate of 8.0% and terminal growth rate of 3.0%.
Stryker Corporation is currently considered overvalued based on its Discounted Cash Flow (DCF) valuation and Relative Valuation, which estimates its share price to be $286.0, compared to a market price of around $383.4. This suggests a potential overvaluation of 25.4%.